Advertisement

Topics

Companies Related to "Clofarabine in High Risk Myelodysplastic Syndrome (MDS)" [Most Relevant Company Matches] RSS

15:26 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Clofarabine in High Risk Myelodysplastic Syndrome (MDS)" found in our extensive corporate database of over 50,000 company records.

Showing "Clofarabine High Risk Myelodysplastic Syndrome" Companies 1–25 of 5,100+

Relevant

The Myelodysplastic Syndromes Foundation, Inc.

The Myelodysplastic Syndromes Foundation, Inc. is a multi-disciplinary, international organization devoted to the prevention, treatment, and study of the myelodysplastic syndromes. The organization is based upon the premise that international cooperation will accelerate the process leading to the control and cure of these diseases. For further information,...


Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...


MDS Foundation

The Myelodysplastic Syndromes Foundation, Inc. is a multi-disciplinary, international organization devoted to the prevention, treatment, and study of the myelodysplastic syndromes. The organization is based upon the premise that international cooperation will accelerate the process leading to the control and cure of these diseases. For further information,...

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...

Imago BioSciences

Imago BioSciences is a clinical-stage, venture-backed pharmaceutical company focused on improving the management of proliferative diseases of the bone marrow and modulation of the immune system. The company is currently focused on neoplastic diseases of the bone marrow including acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibr...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education, and advocacy. Formally established in 2009, the Foundation’s primary focus is to support the Linda Crnic Institute for Down Syndrome, the first academic home in the ...

The Myelodysplastic Syndromes (MDS) Foundation

Cellerant Therapeutics Inc.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in pa...

Angelman Syndrome Foundation

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginning in 2005. For more information on the Foundation, please visit www.angelman.org.

Dynogen Pharmaceuticals

Dynogen is a biopharmaceutical company developing more effective drugs for gastrointestinal (GI) and genitourinary (GU) disorders, including irritable bowel syndrome (IBS) and overactive bladder (OAB). We focus on compounds that have previously been in the clinic and therefore have known safety and pharmacokinetic profiles. This approach, combined with the experience of the Dynogen team, enables...

Priska

Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessment consists of a 5-question survey and fits each patient into one of three risk categories: low risk, moderate risk or high risk. The peer-reviewed tool is highly trusted and wid...

International Rett Syndrome Foundation

Rett syndrome (RTT), a brain disorder affecting development in childhood, has been identified almost exclusively in females. RTT results in severe movement and communication problems following apparently normal development for the first six months of life. The characteristic features include loss of speech and purposeful hand use, occurrence of repetitive hand movements, abnormal walking, abnorm...

AT-RISK International, LLC

Founded by experts with law enforcement, military and intelligence backgrounds, AT-RISK International, LLC provides security training, protection, threat analysis, consulting and investigations worldwide. Established on the philosophy of proactive security, AT-RISK specializes in assessment and protection based on advance research, analysis and preparation...

Down Syndrome Association of Los Angeles

Who: Down Syndrome Association of Los Angeles (DSALA) with National Down Syndrome Society Buddy Walk® Spokesperson John C. McGinley, Dr. Cox on the ABC’s SCRUBS; Grand Marshal, Dr. Jim Sears of THE DOCTORS; Honoring Ken Jenkins, Dr. Kelso of SCRUBS with the Buddy Award, Emcees Mark Wallengren and Kristin Cruz of KOST’s Morning Show, a live dan...

The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. www.consynance.com

The Risk Authority Stanford

The Risk Authority Stanford (TRA Stanford) is a healthcare risk management consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivaled expertise, and quantifiable results. TRA Stanford’s origins are rooted within the Stanford University Medical Network, and it continues to provide all ...

Origami Risk LLC

Origami Risk LLC was founded by industry veterans committed to designing intuitive web-based software that streamlines how risk, insurance and claims data is collected, analyzed and shared—ultimately helping users to be more productive and manage the total cost of risk for their organizations or for their clients. Origami Risk is consistently ranked b...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

The Risk Authority

The Risk Authority – Stanford (TRA) is an innovative healthcare risk management consulting firm dedicated to transforming their clients’ risk management practices with cutting-edge solutions, unrivaled industry expertise and quantifiable results. TRA’s origins are rooted within the Stanford University Medical Network. This connection continues toda...

Foundation for Angelman Syndrome Therapeutics (FAST)

Angelman Syndrome (AS) was first described by Dr. Harry Angelman in 1965. Common symptoms include developmental delay and intellectual disabilities, happy demeanor, movement and balance disorder, severe sleep disorders, seizures and limited speech. Most children are diagnosed between the ages of 3-5 but early detection and intervention can make a significant difference in the child's development ...

Summex Health Management

Summex is a national provider of health management services for large-scale employers. Our wellness programs are proven proactive tools that:Help employees avoid preventable illnesses & measurably improve their health Increase worksite productivity & reduce absenteeism Tangibly reduce health care costsSummex helps businesses by developing, implementing and managing comprehensive wellness programs ...

Liberty Healthcare Corporation

Liberty Healthcare Corporation (www.libertyhealthcare.com) has provided specialized and customized programs for mentally ill individuals in the criminal justice system for over 25 years. It is a recognized expert in the management of high risk, challenging populations in secure settings. Liberty currently operates the California Conditional Release Program...

Telik

Telik, Inc. (Nasdaq: TELK) of Palo Alto, CA is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases. Our most advanced development candidate is TELCYTA™ (TLK286), a novel cancer cell-activated chemotherapeutic currently in four Phase 3 registration trials in advanced ovarian cancer and non-small...


More From BioPortfolio on "Clofarabine in High Risk Myelodysplastic Syndrome (MDS)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks